Stiff-man syndrome (SMS) is characterized by fluctuating muscular rigidity
and spasm. Recently, antibodies against glutamic acid decarboxylase (GAD),
the enzyme catalyzing the synthesis of gamma-amino butyric acid (GABA), hav
e been detected in SMS patients. An autoimmune mechanism against GAD was th
us proposed for the suppression of GABAergic inhibitory interneurons, resul
ting in rigidity and spasm. We conducted quantitative investigations on the
ventral horn of the spinal cord and its GAD immunoreactivity, post mortem,
in a SMS patient and four controls. In the spinal cord of the SMS patient,
we found a 70%, 33% and 27% reduction (P < 0.05) in the density of neurons
with somal areas of 1000-1500 mu m(2) 500-1000 mu m(2), and 0-500 mu m(2),
respectively. The density of neurons with a somal area greater than 1500 m
u m(2) was not reduced, although some neurons in this class showed central
chromatolytic changes. The affected muscles exhibited neurogenic atrophy. G
AD-like immunoreactivity in the spinal gray matter was not significantly de
creased. The density of Purkinje cells, known to contain high amounts of GA
D, was not significantly reduced. While the co-occurrence of elevation of a
nti-GAD antibody in the serum and reduction in the density of small spinal
neurons was confirmed, that of smaller alpha-motor neurons and gamma-motor
neurons, the qualitative changes in larger a-motor neurons, and the preserv
ation of spinal GAD-like immunoreactivity and non-spinal GAD-containing neu
rons suggest the involvement of factors other than autoimmune mechanisms th
rough anti-GAD antibodies. More diverse mechanisms may be associated in the
pathogenesis of SMS.